Ensign Peak Advisors, Inc Vericel Corp Transaction History

Ensign Peak Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$22.62 - $32.54 $984,354 - $1.42 Million	43,517 Added 290.89%	58,477 $1.36 Million
Q4 2021 Feb 11, 2022	SELL	$35.2 - $52.6 $649,088 - $969,944	-18,440 Reduced 55.21%	14,960 $588,000
Q3 2021 Nov 12, 2021	BUY	$46.35 - $59.75 $32,445 - $41,825	700 Added 2.14%	33,400 $1.63 Million
Q2 2021 Aug 13, 2021	BUY	$47.2 - $67.81 $1.17 Million - $1.68 Million	24,800 Added 313.92%	32,700 $1.72 Million
Q1 2021 May 12, 2021	BUY	$30.93 - $59.48 $244,347 - $469,892	7,900 New	7,900 $439,000

291

50.7M

98.2K

135K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.45B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.